Sangamo Therapeutics

SGMO

SGMO
Sangamo Therapeutics Stock Quote
$6.72 -$0.16 -2.4%
Price as of February 27, 2020, 3:55 p.m. EST View Interactive SGMO Charts

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Interactive Chart


News & Analysis: Sangamo Therapeutics

The Fool has written over 100 articles on Sangamo Therapeutics.

All

Market Moves

Earnings










What Happened in the Stock Market Today

Sangamo Therapeutics reported positive data on its gene therapy for hemophilia, and CannTrust Holdings received a noncompliance report from Canadian authorities.